GWAS meta-analysis of 16 852 women identifies new susceptibility locus for endometrial cancer.
暂无分享,去创建一个
Harvey Risch | Peter Kraft | Mark McEvoy | Rodney J Scott | Lucy Xia | Jennifer Prescott | John Attia | Brian E Henderson | Loic Le Marchand | Jirong Long | Jolanta Lissowska | Ian Tomlinson | Alison M Dunning | Wei Zheng | Paul D P Pharoah | Montserrat Garcia-Closas | David J Hunter | Douglas F Easton | Stephen Chanock | Herbert Yu | Noel S Weiss | Irene Orlow | Xin Sheng | Elizabeth G Holliday | Jennifer Doherty | Susan E Hankinson | Constance Turman | Maggie Gorman | Lingeng Lu | C. Friedenreich | S. Chanock | M. García-Closas | P. Hartge | D. Hunter | T. Rebbeck | B. Henderson | C. Haiman | A. Spurdle | D. Easton | P. Kraft | R. Scott | P. Pharoah | S. Hankinson | L. Le Marchand | Zhaoming Wang | J. Long | X. Shu | Y. Xiang | W. Zheng | A. Dunning | Deborah J. Thompson | L. Brinton | J. Lissowska | M. Crous-Bou | I. Tomlinson | J. Attia | E. Holliday | D. J. Van Den Berg | P. Horn-Ross | N. Weiss | M. McEvoy | S. Olson | H. Risch | Herbert Yu | C. Sacerdote | I. Orlow | J. Doherty | S. Hodgson | J. Painter | X. Liang | Lynn Martin | M. Gorman | I. De Vivo | Hannah P. Yang | A. Magliocco | Xin Sheng | Loreall Pooler | Lucy Y. Xia | Chu Chen | N. Wentzensen | L. Cook | M. Gaudet | T. O’Mara | Lingeng Lu | Constance Turman | A. Black | J. Prescott | Sara H Olson | Zhaoming Wang | Amanda B Spurdle | Xiao-Ou Shu | Patricia Hartge | David Van Den Berg | Immaculata De Vivo | Amanda Black | Timothy R Rebbeck | Shirley Hodgson | Carlotta Sacerdote | Chu Chen | Yong-Bing Xiang | Deborah J Thompson | Linda S Cook | Mia M Gaudet | Lynn Martin | Louise Brinton | Loreall Pooler | Christopher Haiman | Timothy H. T. Cheng | Maxine M. Chen | Christine M Friedenreich | Anthony M Magliocco | Veronica Wendy Setiawan | Hannah P Yang | Marta Crous-Bou | Jodie N Painter | Tracy A O'Mara | Pamela L Horn-Ross | Radhai Rastogi | Maxine M Chen | Timothy Ht Cheng | Xiaolin Liang | Frederick Schumacher | Nicholas Wentzensen | X. Sheng | R. Rastogi | F. Schumacher | V. Wendy Setiawan | P. Horn‐Ross | Radhai Rastogi | Lucy Y. Xia | R. Scott | D. Hunter | R. Scott | B. Henderson | R. Scott | Lucy Xia
[1] F. Takeuchi,et al. Confirmation of Multiple Risk Loci and Genetic Impacts by a Genome-Wide Association Study of Type 2 Diabetes in the Japanese Population , 2009, Diabetes.
[2] Genome-Wide Association Study Identifies a Locus at 7p15.2 Associated With Endometriosis , 2011 .
[3] P. Donnelly,et al. A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.
[4] Manolis Kellis,et al. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..
[5] H. Hakonarson,et al. Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma , 2012, Nature Genetics.
[6] K. Schmid,et al. SOX4, SOX11 and PAX6 mRNA expression was identified as a (prognostic) marker for the aggressiveness of neuroendocrine tumors of the lung by using next-generation expression analysis (NanoString). , 2015, Future oncology.
[7] You-guang Huang,et al. Down‐regulated SOX4 Expression Suppresses Cell Proliferation, Metastasis and Induces Apoptosis in Xuanwei Female Lung Cancer Patients , 2015, Journal of cellular biochemistry.
[8] A. Spurdle,et al. Most common 'sporadic' cancers have a significant germline genetic component. , 2014, Human molecular genetics.
[9] J. Duke,et al. Cohort profile: The Hunter Community Study. , 2010, International journal of epidemiology.
[10] Yurii S. Aulchenko,et al. ProbABEL package for genome-wide association analysis of imputed data , 2010, BMC Bioinformatics.
[11] X. Yuan,et al. SOX4 is a potential prognostic factor in human cancers: a systematic review and meta-analysis , 2015, Clinical and Translational Oncology.
[12] C. Friedenreich,et al. Genome-wide association study of endometrial cancer in E2C2 , 2013, Human Genetics.
[13] Daixing Zhou,et al. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer , 2015, Molecular and Cellular Biochemistry.
[14] Peggy Hall,et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations , 2013, Nucleic Acids Res..
[15] Peter Kraft,et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array , 2013, Nature Genetics.
[16] Shannon M. Lynch,et al. Maximizing resources to study an uncommon cancer: E2C2—Epidemiology of Endometrial Cancer Consortium , 2009, Cancer Causes & Control.
[17] X. Yang,et al. SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial–mesenchymal transition in vitro , 2013, Prostate Cancer and Prostatic Disease.
[18] J. Aitken,et al. Genetic and environmental contributions to size, color, shape, and other characteristics of melanocytic naevi in a sample of adolescent twins , 1999, Genetic epidemiology.
[19] Pengbo Liu,et al. Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells. , 2006, Cancer research.
[20] Yun Li,et al. METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..
[21] E. Feuer,et al. SEER Cancer Statistics Review, 1975-2003 , 2006 .
[22] D. Tompkins,et al. Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies. , 2014, Gynecologic oncology.
[23] M. Beckmann,et al. Genome-Wide Association Study Identifies a Possible Susceptibility Locus for Endometrial Cancer , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[24] Aung Ko Win,et al. A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer , 2015, Scientific Reports.
[25] Data production leads,et al. An integrated encyclopedia of DNA elements in the human genome , 2012 .
[26] M. Goldacre,et al. Cancer of the body of the uterus: trends in mortality and incidence in England, 1985–2008 , 2012, BJOG : an international journal of obstetrics and gynaecology.
[27] M. Beckmann,et al. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk , 2014, Human molecular genetics.
[28] N. Risch,et al. Evaluating genetic association among ovarian, breast, and endometrial cancer: evidence for a breast/ovarian cancer relationship. , 1989, American journal of human genetics.
[29] Jean-Baptiste Cazier,et al. Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33 , 2010, Nature Genetics.
[30] J. Ioannidis,et al. Meta-analysis methods for genome-wide association studies and beyond , 2013, Nature Reviews Genetics.
[31] C. la Vecchia,et al. Family history of cancer and the risk of endometrial cancer , 2009, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[32] K. Cole,et al. CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus. , 2015, Cancer research.
[33] Wei Li,et al. SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients , 2015, Tumor Biology.
[34] J. Kaprio,et al. Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.
[35] J. Gulcher,et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes , 2007, Nature Genetics.
[36] W. Gauderman. Sample size requirements for association studies of gene-gene interaction. , 2002, American journal of epidemiology.
[37] Gary K. Chen,et al. Meta-analysis identifies common variants associated with body mass index in East Asians , 2012, Nature Genetics.
[38] K. Hemminki,et al. Endometrial cancer in the family-cancer database. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[39] M. Walter,et al. SOX Genes: Architects of Development , 1996, Molecular medicine.
[40] Nazneen Rahman,et al. Chromosome 6p22 locus associated with clinically aggressive neuroblastoma. , 2008, The New England journal of medicine.
[41] P. Visscher,et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits , 2012, Nature Genetics.
[42] R. Broaddus,et al. Endometrial cancer and Lynch syndrome: clinical and pathologic considerations. , 2009, Cancer control : journal of the Moffitt Cancer Center.
[43] Mara,et al. Fine-mapping of the HNF 1 B multicancer locus identi fi es candidate variants thatmediate endometrial cancer risk , 2015 .
[44] Jinjun Zhang,et al. Overweight, Obesity and Endometrial Cancer Risk: Results from a Systematic Review and Meta-Analysis , 2014, The International journal of biological markers.
[45] Gonçalo R. Abecasis,et al. Minimac2: Faster Genotype Imputation , 2015, Bioinform..
[46] R. Young,et al. Super-Enhancers in the Control of Cell Identity and Disease , 2013, Cell.
[47] M. Beckmann,et al. Genome-wide association study identifies a common variant associated with risk of endometrial cancer , 2011, Nature Genetics.
[48] Neal P. Kawas,et al. The CASC15 long intergenic non-coding RNA locus is involved in melanoma progression and phenotype-switching , 2015, The Journal of investigative dermatology.
[49] F. Hu,et al. Common Variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE Genes Are Associated With Type 2 Diabetes and Impaired Fasting Glucose in a Chinese Han Population , 2008, Diabetes.
[50] M. Lupien,et al. Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits , 2014, Genome research.
[51] Simon C. Potter,et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.
[52] M. Beckmann,et al. CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer , 2015, Endocrine-related cancer.
[53] S. Gruber,et al. A population-based study of endometrial cancer and familial risk in younger women. Cancer and Steroid Hormone Study Group. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[54] G. Abecasis,et al. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes , 2010, Genetic epidemiology.
[55] M. Sherman,et al. Recent changes in endometrial cancer trends among menopausal-age U.S. women. , 2013, Cancer epidemiology.
[56] Lin Wang,et al. Association of SOX4 regulated by tumor suppressor miR-30a with poor prognosis in low-grade chondrosarcoma , 2015, Tumor Biology.
[57] William Wheeler,et al. Genome-wide association study identifies multiple loci associated with bladder cancer risk. , 2014, Human molecular genetics.
[58] Yusuke Nakamura,et al. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer , 2014, Nature Genetics.
[59] C. Mathers,et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.
[60] Steven J. M. Jones,et al. Integrated genomic characterization of endometrial carcinoma , 2013, Nature.
[61] Jingqin Luo,et al. Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer. , 2009, Cancer research.
[62] Jonathan Marchini,et al. Modeling interactions with known risk loci—a Bayesian model averaging approach , 2011, Annals of human genetics.
[63] Yu Zhang,et al. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression. , 2012, Cancer research.
[64] Aung Ko Win,et al. Family History and Risk of Endometrial Cancer: A Systematic Review and Meta-analysis , 2015, Obstetrics and gynecology.